Olympus Targets A Bigger Medical Future
A medical company that has some other businesses – that is the shorthand description that Olympus Corp. of the Americas president and CEO Nacho Abia ascribes to a group that has emerged from difficult times with a new strategy, new structure and new determination. Targeted deals and M&A remain as important as ever to the group as it embarks, somewhat reinvented, on a new five-year plan.
You may also be interested in...
When Olympus Corp. re-entered the M&A arena after five years of "back to the basics," it was via the purchase of a company that meets every parameter of its requirements. Nacho Abia says that OR integrator Image Stream Medical should also help the Japanese multinational stay on course to meet value-based – and ambitious mid-term sales – targets.
Olympus Corp. is making a record payment and implementing stricter internal compliance controls and monitoring to avoid prosecution on kickback allegations.
The UK NICE HTA process can have a positive effect on medical device businesses even before a positive decision is made. That is the experience of surgery products innovator Olympus Medical Systems, a top-30 company globally that is laying down a marker in its approach to clinical and cost effectiveness.